NCT03122340View on ClinicalTrials.gov

Polyprenols (Ropren) in Acute Coronary Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 1, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

February 28, 2018

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Ropren

Per os 8 drops 3 times per day for 3 weeks, then 5 drops 3 times per day for 5 weeks

OTHER

Oil

Per os 8 drops 3 times per day for 3 weeks, then 5 drops 3 times per day for 5 weeks

Trial Locations (1)

634012

Cardiology Research Institute, Tomsk

All Listed Sponsors
lead

Tomsk National Research Medical Center of the Russian Academy of Sciences

OTHER

NCT03122340 - Polyprenols (Ropren) in Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter